IRLAB’s new drug shows promise in treating apathy in Parkinson’s patients
Phase 1 trial of IRL757 demonstrates good absorption and safety profile IRLAB Therapeutics AB has announced the successful completion of...
adminph
ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study
Largest real-world study demonstrates significant survival advantage In a landmark study, Johnson & Johnson has announced that ERLEADA (apalutamide) significantly...
Designing drugs that target “twin” cancer proteins
Some proteins in the human body are easy to block with a drug; they have an obvious spot in their...
Insilico Medicine reports positive results for idiopathic pulmonary fibrosis therapy
ISM001-055 shows promise in improving lung function among patients Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has announced...
AlzeCure’s ACD856’s effects to be presented at Alzheimer’s conference
Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid AlzeCure Pharma AB, a company specializing in drugs...
Circular peptides in violets may aid in the fight against glioblastoma
Glioblastoma is one of the most serious brain diseases known. More than 45% of brain cancers are gliomas. Only half...
Great company
ICON celebrates 2024 ‘company of the year’ win ICON continues to celebrate its achievement at the 2024 Clinical Researcher of...
European Commission approves yuvanci for pulmonary arterial hypertension treatment
Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe The European Commission has approved Yuvanci (macitentan...
One in three Americans has a dysfunctional metabolism, but intermittent fasting could help
More than one-third of adults in the United States have metabolic syndrome, a cluster of conditions that significantly raise a...
Dr Alex Dickinson
Sphere Fluidics has appointed Dr Alex Dickinson to its Board of Directors Sphere Fluidics has announced the appointment of Dr Alex Dickinson to...
Lots in translation
Harnessing vital patient data for precision in clinical trials In clinical research, leveraging patient data has become a critical factor...
BlueRock Therapeutics' investigational cell therapy bemdaneprocel for Parkinson's disease shows positive data at 24-months
Bayer AG and BlueRock Therapeutics LP, a clinical stage cell therapy company and wholly owned independently operated subsidiary of Bayer...
Scientists design new drug to fight malaria
In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent, prevalent, and deadly...
Sheffield A&E to implement life-saving HIV and hepatitis testing
New government scheme to offer routine opt-out blood tests Starting next week, Sheffield’s Northern General Hospital A&E Department will begin...
Oxford drug design secures funding to combat cystic fibrosis lung infections
£3m programme to accelerate new antimicrobial treatment Oxford Drug Design has been awarded a share of a £3 million Collaborative...
Bayer Co.Lab Shanghai opens as part of global expansion of life science incubator network
Bayer announced today the inauguration of its new life science incubator, Bayer Co.Lab Shanghai, in the Shanghai Innovation (SH-INNO) Park...
Dr Amy Walker
4basebio has announced Dr Amy Walker as Chief Operating Officer 4basebio has announced the appointment of Dr Amy Walker as...
Fabio Gratton
minds + assembly has appointed Fabio Gratton as an Advisor minds + assembly welcomes Fabio Gratton as an Advisor to...
Paving the way for new treatments
A University of Missouri researcher has created a computer program that can unravel the mysteries of how proteins work together...
Cancer Grand Challenges launches global initiative to take on toughest problems
International think tanks to shape future of cancer research funding Cancer Grand Challenges, a pioneering initiative co-founded by Cancer Research...
